Page 2 - Stephaniel Graff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephaniel graff. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephaniel Graff Today - Breaking & Trending Today

Dr Graff on the Impact of Endocrine Therapy Interruption on Conception in Breast Cancer Survivors

Stephanie L. Graff, MD, discusses the advantages of interrupting endocrine therapy in premenopausal patients with endocrine-responsive breast cancer who are seeking to conceive, based on findings from the phase 3 POSITIVE trial. ....

Stephaniel Graff , Brown University Legorreta Cancer Center , Breast Cancer Translational Research Disease Group , Warren Alpert Medical School , Lifespan Cancer Institute , Brown University , Legorreta Cancer Center , Onclive Tv , Breast Cancer , Endocrine Therapy Interruption , Phase 3 Positive Trial , Endocrine Responsive Breast Cancer , Hr Positive Breast Cancer ,

Continued Research Underscores the Need to Explore New Approaches Across the Breast Cancer Armamentarium

Stephanie L. Graff, MD, expands on treatment options available for patients with premenopausal breast cancer who are trying to conceive, highlighting the POSITIVE trial in women with endocrine-responsive breast cancer. ....

United States , Dana Farber Cancer Institute , Stephaniel Graff , Annh Partridge , Saram Tolaney , Aditya Bardia , Komal Jhaveri , Mary Ann Fenton , Brown University , Lifespan Cancer Institute , Drug Administration , Hospital Cancer Center , American Society Of Clinical Oncology , Breast Cancer Translational Research Disease Group , Memorial Sloan Kettering Cancer Center , Science Summit , Rhode Island Hospital , Breast Cancer Translational Research Disease , Clinical Oncology , Massachusetts General Hospital Cancer , Ann Fenton , Patients With Premenopausal Breast Cancer , Positive Trial , Massachusetts General Hospital Cancer Center ,

Dr Graff on the Investigation of Datopotamab Deruxtecan in HR+ Breast Cancer and TNBC

Stephanie L. Graff, MD, discusses current and planned investigations of the emerging antibody-drug conjugate datopotamab deruxtecan in patients with metastatic hormone receptor–positive breast cancer and triple-negative breast cancer. ....

San Antonio , United States , Stephaniel Graff , Brown University Legorreta Cancer Center , Breast Cancer Translational Research Disease Group , Lifespan Cancer Institute , Warren Alpert Medical School , Brown University , Legorreta Cancer Center , Antonio Breast Cancer Symposium , Onclive Tv , Breast Cancer , Datopotamab Deruxtecan , Hr Breast Cancer ,

Dr Graff on the Evaluation of Trastuzumab Deruxtecan in HER2-Zero Breast Cancer

Stephanie L. Graff, MD, discusses the evaluation of trastuzumab deruxtecan in patients with HER2-zero metastatic breast cancer in the ongoing, phase 2 DESTINY-Breast06 trial. ....

Stephaniel Graff , Breast Cancer Translational Research Disease Group , Warren Alpert Medical School , Brown University Legorreta Cancer Center , Lifespan Cancer Institute , Brown University , Legorreta Cancer Center , Neoadjuvant Her2 , Onclive Tv , Breast Cancer ,

Dr Graff on Data From HER2CLIMB Exploratory Analysis in HER2+ Breast Cancer With Brain Metastases

Stephanie L. Graff, MD, discusses data from an exploratory analysis of patients with HER2-positive breast cancer and brain metastases enrolled to the phase 2 HER2CLIMB study, and emphasizes the need for such research efforts to move the needle forward for this population.
....

Stephaniel Graff , Lifespan Cancer Institute , Brown University Legorreta Cancer Center , Warren Alpert Medical School , Breast Cancer Translational Research Disease Group , Brown University , Legorreta Cancer Center , Breast Cancer , Onclive Tv , Brain Metastases , Her2 Breast Cancer ,